Position in FTRE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,036,834
+$1,256,277 QoQ
Shares Held
232,002
-21.4% QoQ
Ownership
0.244%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 334 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FTRE Over Time
Shares Held
Position Value (USD)
Derivatives in FTRE
reported options exposure · as of Mar 31, 2025CallValue
$234,050
CallShares
31,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. FTRE ranks #151 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in FTRE
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,036,834 | 232,002 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,780,557 | 295,176 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $12,945,156 | 750,444 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $12,840,690 | 1,525,023 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $4,230,276 | 856,332 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,577,159 | 341,346 | Shares | Defined | 2025-05-15 | |
| 2025-03-31 | $234,050 | 31,000 | Call | Defined | 2025-05-15 | |
| 2024-12-31 | $6,213,579 | 333,168 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $15,189,180 | 759,459 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $32,997,365 | 1,413,769 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $59,200,397 | 1,474,848 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $50,053,298 | 1,434,192 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $33,669,095 | 1,177,653 | Shares | Defined | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||